New RNA test could end diagnostic odyssey for rare disease patients

NCT ID NCT07075107

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether analyzing RNA from blood and skin samples can find hidden genetic causes in people with rare diseases like intellectual disability. Researchers will compare results from both tissues to see which works best. The goal is to reduce the years of uncertainty many patients face without a diagnosis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could provide a new way to diagnose rare genetic diseases faster, ending long searches for answers for many patients.

What could go wrong

This is a small, early-stage study (62 participants) focused on testing a method, not a treatment. It may not work for all patients or lead to immediate benefits.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RARE GENETIC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hereditary disease intellectual disability Rare Diseases

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Assistance publique - hôpitaux de Marseille

    RECRUITING

    Marseille, Provence-Alpes-Côt-d'Azue, 13354, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact